title: [Screening for distress in women with breast cancer diagnosed for the first time: employment of HADS-D and PO-Bado].
abstract: OBJECTIVE
  In the context of an intensification of efforts to ensure sufficient psychooncological care for breast-cancer patients, the discussion concerning valid psychometric screening instruments gains a special relevance.
  
  
  METHODS
  The discriminant and diagnostic validity of HADS-D and PO-Bado were investigated in a sample of 123 women with breast cancer diagnosed for the first time.
  
  
  RESULTS
  An ROC analysis revealed a cut-off score of greater than 9 for the subscale anxiety (sensitivity: 50%; specificity: 90%) for the use of HADS-D among breast cancer patients, whereas the recommended cut-off value was greater than 7 (sensitivity: 56%; specificity: 80%) for the subscale depression. Based on the anxiety and depression scores measured by HADS-D, 74% of the clinical cases could be classified correctly. Scores for physical and mental distress measured with PO-Bado were significantly lower in the investigated sample than in the control sample.
  
  
  CONCLUSIONS
  HADS-D has only a moderate sensitivity for the group at hand. PO-Bado is a comprehensive basic documentation for specific psychooncological distress, though without cut-off values it is not useful as a screening instrument.
authors.affiliation: Klinik für Psychosomatische Medizin und Psychotherapie, Universitätsklinikum Essen. yesim.erim@uni-essen.de
authors.forename: Yesim
authors.initials: Y
authors.lastname: Erim
authors.forename: Mingo
authors.initials: M
authors.lastname: Beckmann
authors.forename: Gabriele
authors.initials: G
authors.lastname: Gerlach
authors.forename: Sherko
authors.initials: S
authors.lastname: Kümmel
authors.forename: Carsten
authors.initials: C
authors.lastname: Oberhoff
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Senf
authors.forename: Rainer
authors.initials: R
authors.lastname: Kimmig
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001008:Anxiety Disorders / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D001943:Breast Neoplasms / Q000453:epidemiology / Q000523:psychology* / Q000601:surgery; D015897:Comorbidity; D003430:Cross-Sectional Studies; D003866:Depressive Disorder / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D019468:Disease Management; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008403:Mass Screening; D008875:Middle Aged; D010555:Personality Inventory / Q000706:statistics & numerical data*; D011446:Prospective Studies; D011594:Psychometrics; D011613:Psychotherapy; D012017:Referral and Consultation